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The production of foods with antihypertensive activity has particular interest given the important role of diet in the prevention and treatment of hypertension.
Enzymatic hydrolysis using one or a combination of food-grade enzymes can be a cheap and reproducible alternative to fermentation for the production of 
antihypertensive peptides.
Introduction
Laboratory-scale Production at large-scale
Objective: To identify active peptides from a enzymatic hydrolysate of bovine casein with the aim of producing a novel food ingredient based 
on this hydrolysate.
Identification of antihypertensive peptides
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Determination of ACE-inhibitory activity and ORAC-FL
Fraction Casein fragment Sequence IC50
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ORAC-FL
(mol Trolox/ mol peptide)
F3 S1-CN f(90-94) RYLGY 0.71 2.83
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Casein-ingredient was incorporated into yogurts and stored at 4 ºC
for a month.
The peptides content was quantified in WSEs by RP-HPLC-MS.
CONCLUSIONS
0 2 4 6 8 10
-30
-20
-10
20 24
*
** **
**
**
Time (h)
C
ha
ng
es
 in
 S
B
P
**
**
**
*
   
**p<0.01 *p<0.05 
0 1 2 3 4
Time (week)
Pe
pt
id
es
 c
on
te
n
Clinical studies are being carried out toCasein hydrolysis with pepsin leads to the formation of antihypertensive peptides.
• Contreras et al. (2009). Int. Dairy J. 19, 566-573
• Miguel et al. (2009). Food Chem. 112, 211-214
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evaluate the antihypertensive action of casein
hydrolysate in humans.
Peptide RYLGY is one of the most potent ACE-inhibitors identified from food proteins (IC50,
0,71 M).
RYLGY and AYFYPEL had antihypertensive activity in SHR, and was comparable to VPP.
Hydrolysis was successfully scaled-up, and antihypertensive activity of the casein-ingredient 
was confirmed in SHR.
The casein-ingredient was well incorporated into yogurt, and antihypertensive peptides 
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